|
|
Volumn 28, Issue 12, 2010, Pages
|
|
Inflammatory pathogenesis of prostate cancer and celecoxib
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
I KAPPA B KINASE ALPHA;
KI 67 ANTIGEN;
MASPIN;
PROSTAGLANDIN;
ANTINEOPLASTIC AGENT;
CYCLOOXYGENASE 2 INHIBITOR;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
TUMOR MARKER;
CANCER GRADING;
CARCINOGENESIS;
CD20+ B LYMPHOCYTE;
CD3+ T LYMPHOCYTE;
CD68+ MACROPHAGE;
DRUG EFFECT;
HUMAN;
IMMUNOPHENOTYPING;
INFLAMMATION;
INFLAMMATORY CELL;
LETTER;
MACROPHAGE;
OXIDATIVE STRESS;
PATHOGENESIS;
PRECANCER;
PRIORITY JOURNAL;
PROLIFERATIVE INFLAMMATORY ATROPHY;
PROSTATE CANCER;
ADENOCARCINOMA;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
BLOOD;
IMMUNOLOGY;
MALE;
METABOLISM;
NOTE;
PATHOLOGY;
PROSTATE TUMOR;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ANTINEOPLASTIC AGENTS;
CHEMOTHERAPY, ADJUVANT;
CYCLOOXYGENASE 2 INHIBITORS;
HUMANS;
MALE;
NEOADJUVANT THERAPY;
PROSTATIC NEOPLASMS;
PYRAZOLES;
SULFONAMIDES;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 77951649828
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2009.27.1098 Document Type: Letter |
|
Times cited : (5)
|
|
References (4)
|
